{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:03:27Z","timestamp":1790471007854,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tunisian Ministry of Higher Education, Research and Technology","award":["LR11IPT02"],"award-info":[{"award-number":["LR11IPT02"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.molimm.2017.06.248","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T09:34:15Z","timestamp":1499679255000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients"],"prefix":"10.1016","volume":"90","author":[{"given":"Leila","family":"Ben-Khemis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla","family":"Mekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imen","family":"Ben-Mustapha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Rouault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fethi","family":"Mellouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Khemiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Bejaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Essaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saayda","family":"Ben-Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Boughamoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saida","family":"Hassayoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Ben-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed-Ridha","family":"Barbouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2017.06.248_bib0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2011.06260.x","article-title":"Primary immunodeficiencies in highly consanguineous North African populations","volume":"1238","author":"Barbouche","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2017.06.248_bib0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10875-016-0299-9","article-title":"A founder effect of c.257+ 2T>C mutation in NCF2 gene underlies severe chronic granulomatous disease in eleven patients","volume":"36","author":"Ben-Farhat","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.molimm.2017.06.248_bib0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10875-013-9863-8","article-title":"Clinical, immunological and genetic findings of a large Tunisian series of major histocompatibility complex class II deficiency patients","volume":"33","author":"Ben-Mustapha","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.molimm.2017.06.248_bib0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00251-013-0739-0","article-title":"A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients","volume":"66","author":"Ben-Mustapha","year":"2014","journal-title":"Immunogenetics"},{"key":"10.1016\/j.molimm.2017.06.248_bib0025","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1086\/301869","article-title":"Mutation rate in human microsatellites: influence of the structure and length of the tandem repeat","volume":"62","author":"Brinkmann","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molimm.2017.06.248_bib0030","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1074\/jbc.R112.429274","article-title":"Understanding human glycosylation disorders: biochemistry leads the charge","volume":"288","author":"Freeze","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2017.06.248_bib0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/jmg.2003.017962","article-title":"Estimating the age of rare disease mutations: the example of Triple-A syndrome","volume":"41","author":"Genin","year":"2004","journal-title":"J. Med. Genet"},{"key":"10.1016\/j.molimm.2017.06.248_bib0040","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1128\/MCB.00802-07","article-title":"Agm1\/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development","volume":"27","author":"Greig","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molimm.2017.06.248_bib0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.mop.0000133636.56790.4a","article-title":"Congenital disorders of glycosylation: a booming chapter of pediatrics","volume":"16","author":"Jaeken","year":"2004","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.molimm.2017.06.248_bib0050","series-title":"Inborn Metabolic Diseases: Diagnosis and Treatment","first-page":"607","article-title":"Congenital disorders of glycosylation","author":"Jaeken","year":"2012"},{"key":"10.1016\/j.molimm.2017.06.248_bib0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-1119(99)00543-0","article-title":"Cloning and characterization of complementary DNA encoding human N-acetylglucosamine-phosphate mutase protein","volume":"242","author":"Li","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.molimm.2017.06.248_bib0060","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.clim.2015.10.002","article-title":"Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene","volume":"161","author":"Lundin","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.molimm.2017.06.248_bib0065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1371\/journal.pgen.0030071","article-title":"Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan","volume":"3","author":"Miller","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molimm.2017.06.248_bib0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00251-015-0878-6","article-title":"Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients","volume":"68","author":"Ouadani","year":"2016","journal-title":"Immunogenetics"},{"key":"10.1016\/j.molimm.2017.06.248_bib0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1469-1809.2002.00103.x","article-title":"Identification of human phosphoglucomutase 3 (PGM3) as N-acetylglucosamine-phosphate mutase (AGM1)","volume":"66","author":"Pang","year":"2002","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.molimm.2017.06.248_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.02.025","article-title":"Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels","volume":"133","author":"Sassi","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2017.06.248_bib0085","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10545-014-9720-9","article-title":"Congenital disorders of glycosylation: new defects and still counting","volume":"37","author":"Scott","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.molimm.2017.06.248_bib0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","article-title":"PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia","volume":"95","author":"Stray-Pedersen","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molimm.2017.06.248_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.02.013","article-title":"Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment","volume":"133","author":"Zhang","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2017.06.248_bib0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-1809.2006.00308.x","article-title":"The fate of 12 recessive mutations in a single village","volume":"71","author":"Zlotogora","year":"2007","journal-title":"Ann. Hum. Genet."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017304200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017304200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T20:52:09Z","timestamp":1530132729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589017304200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":20,"alternative-id":["S0161589017304200"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2017.06.248","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2017.06.248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}